Aller au contenu principal
Accès ouvert déclaré 2026 article

ICU-acquired infection in neutropenic patients

0Citations signalées, ce qui n’est pas une note de qualité
9Institutions déclarées
2Pays d’affiliation déclarés

Rattachement africain : fr, us. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

BACKGROUND: Among neutropenic patients, sepsis is a frequent cause of ICU admission, and its epidemiology is well described, but data on infection acquired during the ICU stay (ICU-AI) are lacking. AIM: We aim to describe, using a large nationwide cohort study, the incidence of ICU-AI for neutropenic patients in a large network of French intensive care units (ICUs). METHODS: This study was conducted using the healthcare-associated infection surveillance cohort “REA-REZO” involving 265 participating ICUs. All patients admitted to a participating ICU from 1st January 2018 to 31th December 2023, for more than 48 h were eligible. The primary endpoint was the rate of ICU-AI. A matched analysis was conducted using non-parsimonious regression model to compare neutropenic and non-neutropenic patients. FINDINGS: Matching process resulted in well-balanced 7545 patients’ pairs. ICU-AI incidence rate was 14.9 versus 13.0 AI per 1000 patients days in the neutropenic group vs non-neutropenic group (Incidence Rate Ratio [IRR] = 1.15 [1.05, 1.25] p = 0.002) with higher incidence rate for bloodstream infection (BSI) (p < 0.001) but comparable incidences rates of pneumonia (p = 0.503) and central-line associated BSI (p = 0.100). There were less enterobacterales among ICU-AI of the neutropenic group (33.8% vs 45.4%, p < 0.001), but higher rate of coagulase negative Staphylococcus (12.0% vs 5.2%, p < 0.001), Enterococcus spp, (8.9% vs 6.0%, p = 0.015) and Candida spp. (10.4% vs 6.2%, p = 0.001). Rates of ICU-AI involving multidrug resistant micro-organisms did not differed, neither did the rate of ICU-AI involving non fermenting Gram-negative bacilli. CONCLUSION: Neutropenic patients had higher ICU-AI incidence as compared with non-neutropenic patients, specifically through an increase of BSI incidence. Microbiology differs between neutropenic patients and non-neutropenic patients with no difference in multidrug resistant microorganism involvement.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
ICU-acquired infection in neutropenic patients
Date Crossref
17/03/2026
Éditeur
Springer Science and Business Media LLC
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Les institutions déclarées

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Neutropenia and Cancer InfectionsNosocomial Infections in ICUSepsis Diagnosis and Treatment

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.